8-K
Current Report
Tempest Therapeutics, Inc. Filed Acc 0001193125-26-027203
Shareholder rights changed · Executive or director change · Shareholder vote results
- Item 3.03 Material modification to rights of security holders
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d70064d8k.htm…